Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Mo-Rez shows 62% response rate in platinum-resistant ovarian cancer


RYBREVANT FASPRO combination shows 77% response rate in first-line advanced head and neck cancer


Ris-Rez cuts progression risk by 67% in Phase III relapsed osteosarcoma trial


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Mapping Future Technology Needs For Real Time Release Testing

Presented by Dr Udayanath Aich, Associate Director at Bristol-Myers Squibb
09th August 2019


In Situ High Speed NIR Imaging & Raman Mapping to Monitor Form Change and Drug Release from Rapidly Disintegrating Tablets

Presented by Patrick Wray, Senior Research Investigator at Bristol-Myers Squibb and Miriam Böhmler, Senior Applications Scientist at WITec GmbH
10th March 2020


Subvisible Particle Identification & Characterisation by Multi-Technique Methods

Presented by Dr. Jonas Hoeg Thygesen, Novo Nordisk Pharmatech. Followed by Colin Merrifield, ProteinSimple
23rd February 2017


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia